Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipoproteinemias

Clinical trial condition

Hyperlipoproteinemias

Explore clinical trials studying Hyperlipoproteinemias. Study availability and eligibility vary by location and protocol.

231 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipoproteinemias trial results

Completed

MARS - Monitored Atherosclerosis Regression Study

NCT00116870

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations: Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine Los Angeles, California, United States

View Trial Details

Completed

Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia

NCT00515307

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Digestive Disease Research Center, Shariati Hospital, North Kargar Ave. Tehran, Iran

View Trial Details

Completed

Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia

NCT00688896

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Amsterdam, Netherlands

View Trial Details

Completed

Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia

NCT00686010

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Amsterdam, Utrecht, Rotterdam, Nijmegen, Arnhem, Groningen, Dordrecht, Hoorn, Groningen Amsterdam, Netherlands

View Trial Details

Completed

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

NCT00134498

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Huntington Beach, California, United States

Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Orange, California, United States

View all 44 locations

View Trial Details

Completed

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

NCT00134511

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Pfizer Investigational Site Boston, Massachusetts, United States

Pfizer Investigational Site Chicoutimi, Quebec, Canada

Pfizer Investigational Site Ste-Foy, Quebec, Canada

Pfizer Investigational Site Parktown, Johannesburg, South Africa

View Trial Details

Completed

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

NCT00134485

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Pfizer Investigational Site San Diego, California, United States

Pfizer Investigational Site Washington D.C., District of Columbia, United States

Pfizer Investigational Site Lutz, Florida, United States

Pfizer Investigational Site Tampa, Florida, United States

View all 41 locations

View Trial Details

Completed

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

NCT00345657

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia, Dyslipidemias, +11 more
Locations: Family Medical Care of Tulsa Tulsa, Oklahoma, United States

View Trial Details

Completed

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

NCT00004809

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Dyslipidemias, +13 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Specified Drug-use Survey of Leqvio for s.c. Injection.

NCT06275724

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolaemia, +12 more
Locations: Novartis Investigative Site Handa, Aichi-ken, Japan

Novartis Investigative Site Ichinomiya, Aichi-ken, Japan

Novartis Investigative Site Ichinomiya, Aichi-ken, Japan

Novartis Investigative Site Komaki, Aichi-ken, Japan

View all 107 locations

View Trial Details